Mo1757 THE RISK OF BLOOD TRANSFUSION WITH THE USE OF PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS DURING HOSPITALIZATION FOR INFLAMMATORY BOWEL DISEASE EXACERBATION: A TIME TO EVENT ANALYSIS
Inflammatory bowel disease (IBD) exacerbation increases the risk of venous thromboembolism (VTE), and current guidelines recommend pharmacologic VTE prophylaxis (PVTEP) during hospitalization. Compliance with these guidelines is poor, in part due to the physician and patient concerns that PVTEP may worsen anemia and/or bleeding. This risk in the IBD population is poorly defined.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Samreen Khuwaja, Nina Kohn, Shreya Sanghani, Sundas Khan, Arun Swaminath, Keith S. Sultan Tags: Poster abstracts Source Type: research
More News: Anemia | Bleeding | Blood Transusion | Endoscopy | Gastroenterology | Inflammatory Bowel Disease | Thrombosis